Abstract
Overview
Introduction
Counterfeit medicines are a global problem costing patient' s their health and
the pharmaceutical industry and governmental organizations millions of dollars
per year. Although there is no one preventative strategy, there are several
measures that can be employed simultaneously to reduce the risk of fake
medicines entering the pharmaceutical supply chain.
Scope
- Overview of the prevalence and drivers of counterfeit medicines, examining
the economic and health cost of fake medicines
- Analysis of how counterfeit medicines enter the market, and strategies
taken to tighten up supply chain security
- Assessment of key anti-counterfeiting technologies employed by
pharmaceutical manufacturers, supported by case study analysis
- Examination of governmental and NGO based initiatives to improve
regulation, legislation and enforcement of anti-counterfeiting protocols
Report Highlights
Incidents of counterfeit medicines are on the increase. However, reported
figures only represent the tip of the iceberg, particularly in developing
countries due to the insufficient anti-counterfeiting resources available
Parallel importation and online pharmacies are increasingly becoming the route
of choice for counterfeiters to distribute fake medicines to patients on a
global scale. Find out why, and what is being done to address these matters
Currently, 2D-barcodes and radio frequency identification tagging (RFID) are
the two most prominent track & trace technologies. However, with the FDA
having no preference, which technologies will pharmaceutical companies opt for?
Reasons to Purchase
- Identify the cause, prevalence and drivers of counterfeiting in the world
today
- Evaluate which anti-counterfeiting strategies are available, and which
ones to adopt
- Understand what anti-counterfeiting regulations and legislations will
likely affect the pharmaceutical industry in the near future
| 
View Cart
